Annualized recurring revenue (“ARR”) of $832 millionTotal revenue of $210 million; Product subscriptions revenue of $204 millionGAAP loss from ...

Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screenedPrevious open label trial ...

GPT-5.5 Instant is now the default ChatGPT model. It makes fewer things up, answers more concisely, and finally remembers ...

Q1 2026 earnings call highlights: 1.15x book-to-bill, FIT AI launch, guidance reiterated, and key risks—read the insights now.

Kim McGuire had already spent nearly two weeks at St. Anthony Hospital in Oklahoma City when a hospital case manager ...

The AI company is pushing further into a sector critical to its enterprise business as it targets revenue growth and barrels ...

NFEPS Guidance -- Fiscal 2026 range raised by $0.20 to $3.48-$3.62 per share, following an earlier $0.25 increase after ...

The conference sent roughly $79 million to each of its full-share schools, albeit the amount varied due to CFP participation.

Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screened Previous open label trial data presented at SIRS 2026 showed no safety or drug-dr ...

As a founder of an AI Governance platform, I sometimes hear customers say they will think about governance once they have the AI solution or are ready for production. No board would hire a graduate ...

Rula reports that in 2026, access to mental healthcare remains a challenge despite growing awareness, with financial stress ...